Select Bibliography

Filter by any of these (after searching):

CALGB-150007

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 38 items

Par-4 Down-regulation Promotes Breast Cancer Recurrence by Preventing Multinucleation following Targeted Therapy

Alvarez, James V. , Pan, Tien-chi , Ruth, Jason , Feng, Yi ... - - Cancer Cell - 2013

Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - CALGB-150007

Activating Mutations in PIK3CA or AKT1 in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657)

Boudreau, A. , Yau, C. , Petrillo, L. , Stemke-Hale, K. , Mills, G. ... - SABCS - Cancer Res - 2011

Abstract - Secondary - Primary - Correl Sci NOS - ACRIN-6657 , CALGB-150007

Comparison of Residual Cancer Burden, American Joint Committee on Cancer staging and Pathologic Complete Response in Breast Cancer after Neoadjuvant Chemotherapy: Results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

Campbell, Jeffrey I. , Yau, Christina , Krass, Polina , Moore, Dan ... - - Breast Cancer Res Treat - 2017

Manuscript - Secondary - Primary - Breast - CALGB-150007

The Prognostic Implications of Macrophages Expressing Proliferating Cell Nuclear Antigen in Breast Cancer Depend on Immune Context

Campbell, Michael J. , Wolf, Denise , Mukhtar, Rita A. ... - - PLoS ONE - 2013

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150007

Pretreatment vitamin D level and response to neoadjuvant chemotherapy in women with breast cancer on the I-SPY trial (CALGB 150007/150015/ACRIN6657)

Clark, Amy S , Chen, Jinbo , Kapoor, Shiv , Friedman, Claire ... - - Cancer Med - 2014

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150007

Local Recurrence Rates are Low in High-Risk Neoadjuvant Breast Cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657)

Cureton, Elizabeth L. , Yau, Christina , Alvarado, Michael D. ... - - Ann Surg Oncol - 2014

Manuscript - Secondary - Primary - Breast - CALGB-150007

Loss of p27 expression and response to neoadjuvant chemotherapy: Results from the I-SPY Trial (CALGB150007/150012, ACRIN6657)

Demichele, A. , Dunn, L. , Gimotty, P. , Livasy, C. , Perou, C. ... - ASCO - J Clin Oncol - 2009

Abstract - Secondary - Primary - Correl Sci NOS - CALGB-150007

Comparison of community and central Her2 assessment on outcome of neoadjuvant chemotherapy in the I-SPY trial (CALGB 150007/150012, ACRIN 6657)

Demichele, A. , Yau, C. , Zhu, J. , Wuhfkuhle, J. , Lenburg, M. E. ... - SABCS - Cancer Res - 2011

Abstract - Secondary - Primary - Correl Sci NOS - ACRIN-6657 , CALGB-150007

Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657

Esserman, L. J. , Berry, D. A. , Demichele, A. , Carey, L. ... - - J Clin Oncol - 2012

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150007 , CALGB-150012 , ACRIN-6657

Breast cancer molecular profiles and tumor response of neoadjuvant doxorubicin and paclitaxel: The I-SPY Trial (CALGB 150007/150012, ACRIN 6657)

Esserman, L. J. , Perou, C. M. , Cheang, M. , Demichele, A. ... - ASCO - J Clin Oncol - 2009

Abstract - Secondary - Primary - Correl Sci NOS - ACRIN-6657 , CALGB-150007

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

Esserman, Laura J. , Berry, Donald A. , Cheang, Maggie C. U. ... - - Breast Cancer Res Treat - 2012

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150007

Sentinel node biopsy performed in the neoadjuvant setting for Breast Cancer: Results from the CALGB 150007 & 150012/ACRIN 6657 I-SPY TRIAL

Gomez, R. , Zakhireh, J. , Moore, D. , Demichelle, A. , Przewoznik, J. ... - SABCS - Cancer Res - 2009

Abstract - Secondary - Primary - Correl Sci NOS - ACRIN-6657 , CALGB-150007

Genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer

Hatzis, Christos , Pusztai, Lajos , Valero, Vicente ... - - JAMA - 2011

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150007

Comparison of MRI endpoints for assessing breast cancer response to neoadjuvant treatment: preliminary findings of the American College of Radiology Imaging Network (ACRIN) trial 6657

Hylton, N. M. , Blume, J. , Bernreuter, W. , Pisano, E. , Rosen, M. ... - SABCS - Cancer Res - 2009

Abstract - Primary - Preliminary - Breast - CALGB-150007

MRI Assessment of Breast Cancer Response to Neoadjuvant Chemotherapy: Preliminary Findings of the American College of Radiology Imaging Network (ACRIN) Trial 6657

Hylton, N. M. , Blume, J. , Bernreuter, W. , Pisano, E. , Rosen, M. ... - RSNA - Radiological Society of North America 94th Scientific Assembly and Annual Meeting - 2008

Abstract - Primary - Preliminary - Breast - CALGB-150007

MRI tumor volume for predicting response to neoadjuvant chemotherapy in locally advanced breast cancer: Findings from ACRIN trial 6657/CALGB 150007

Hylton, N. M. , Blume, J. , Gastonis, C. , Gomez, R. , Bernreuter, W. ... - ASCO - J Clin Oncol - 2009

Abstract - Secondary - Primary - Breast - ACRIN-6657 , CALGB-150007

Locally Advanced Breast Cancer: MR Imaging for Prediction of Response to Neoadjuvant Chemotherapy—Results from ACRIN 6657/I-SPY TRIAL

Hylton, Nola M. , Blume, Jeffrey D. , Bernreuter, Wanda K. ... - - Radiology - 2012

Manuscript - Primary - Primary - Breast - CALGB-150007

Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival—Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL

Hylton, Nola M. , Gatsonis, Constantine A. , Rosen, Mark A. ... - - Radiology - 2016

Manuscript - Secondary - Primary - Breast - CALGB-150007

Multicenter I-SPY 1 TRIAL (CALGB 150007/150012): Breast cancer stem cells are associated with intrinsic chemoresistance and worse survival

Landis, M. , Yau, C. , Neumeister, V. , Rimm, D. , Esserman, L. ... - SABCS - Cancer Res - 2012

Abstract - Secondary - Primary - Correl Sci NOS - CALGB-150007 , CALGB-150012

RANK expression in primary tumor tissue at the time of diagnosis correlates with risk of subsequent bone metastases in the I-SPY 1 trial (CALGB 150007/150012; ACRIN 6657)

Li, J. , Yau, C. , Campbell, M. , Park, J. W. ... - SABCS - Cancer Res - 2011

Abstract - Secondary - Primary - Correl Sci NOS - ACRIN-6657 , CALGB-150007

Effect of MR Imaging Contrast Thresholds on Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes: A Subgroup Analysis of the ACRIN 6657/I-SPY 1 TRIAL

Li, Wen , Arasu, Vignesh , Newitt, David C. , Jones, Ella F. ... - - Tomography - 2016

Manuscript - Secondary - Primary - Breast - ACRIN 6657 , CALGB-150007

Detection of locally advanced breast cancer in the I-SPY TRIAL (CALGB 150007/150012, ACRIN 6657) in the interval between routine screening

Lin, C. , Moore, D. , Demichele, A. , Ollila, D. W. ... - ASCO - J Clin Oncol - 2009

Abstract - Secondary - Primary - Correl Sci NOS - CALGB-150007

Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial)

Lin, Cheryl , Buxton, Meredith Becker , Moore, Dan , Krontiras, Helen ... - - Breast Cancer Res Treat - 2012

Manuscript - Secondary - Primary - Breast - CALGB-150007 , CALGB-150012

Semi-quantitative protein analysis of HER2 and ER levels in human breast cancer reveals broad expression ranges within HER2+ and ER+ phenotypes

Liotta, L. , Pierobon, M. , Wulfkuhle, J. , Laird, J. , Livasy, C. ... - ASCO - J Clin Oncol - 2009

Abstract - Secondary - Primary - Correl Sci NOS - CALGB-150007

Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer

Lips, Esther H. , Mukhtar, Rita A. , Yau, Christina ... - - Breast Cancer Res Treat - 2012

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150007

Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and response

Magbanua, Mark Jesus M. , Wolf, Denise M. , Yau, Christina ... - - Breast Cancer Res - 2015

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150007

MRI phenotype and tumor subtype affect breast conservation eligibility and MRI accuracy in the I-SPY 1 trial

Mukhtar, R. A. , Hylton, N. M. ... - SABCS - Cancer Res - 2011

Abstract - Secondary - Primary - Breast - CALGB-150007

Lobular breast cancer and NAC: Combined results from the NKI and I-SPY 1 trial

Mukhtar, R. A. , Lips, E. , Wesseling, J. , Livasy, C. , Yau, C. ... - SABCS - Cancer Res - 2011

Abstract - Secondary - Primary - Correl Sci NOS - ACRIN-6657 , CALGB-150007

PCNA+ tumor associated macrophages are associated with M1 and M2 gene expression, and confer poor prognosis in the absence of anti-tumor immune environment

Mukhtar, R. A. , Wolf, D. , Tandon, V. , Zhu, J. , Lenburg, M. ... - SABCS - Cancer Res - 2011

Abstract - Secondary - Primary - Correl Sci NOS - ACRIN-6657 , CALGB-150007

Clinically Meaningful Tumor Reduction Rates Vary by Prechemotherapy MRI Phenotype and Tumor Subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

Mukhtar, Rita A. , Yau, Christina , Rosen, Mark , Tandon, Vickram J. ... - - Ann Surg Oncol - 2013

Manuscript - Secondary - Primary - Breast - CALGB-150007

Features of MRI stromal enhancement with neoadjuvant chemotherapy: a subgroup analysis of the ACRIN 6657/I-SPY TRIAL

Olshen, Adam , Wolf, Denise , Jones, Ella F. , Newitt, David ... - - J Med Imaging (Bellingham) - 2018

Manuscript - Secondary-not-in-original - Primary - Breast - CALGB-150007

Receptor Activator of Nuclear Factor Kappa B (RANK) Expression in Primary Breast Cancer Correlates with Recurrence Free Survival and Development of Bone Metastases in I-SPY1 (CALGB 150007/150012; ACRIN 6657)

Vidula, Neelima , Yau, Christina , Li, Jiali , Esserman, Laura J. ... - - Breast Cancer Res Treat - 2017

Manuscript - Secondary - Primary - Breast - CALGB-150007

Androgen receptor gene expression in primary breast cancer

Vidula, Neelima , Yau, Christina , Wolf, Denise ... - - NPJ Breast Cancer - 2019

Manuscript - Secondary-not-in-original - Primary - Breast - CALGB-150007

Patient-specific integrative pathway analysis using PARADIGM identifies key activities in I-SPY 1 breast cancer patients (CALGB 150007/150012; ACRIN 6657)

Wolf, D. , Yau, C. , Benz, S. , Vaske, C. , Stuart, J. , Roy, R. ... - SABCS - Cancer Res - 2011

Abstract - Secondary - Primary - Correl Sci NOS - ACRIN-6657 , CALGB-150007

Gene expression changes associated with response to neoadjuvant chemotherapy are observed early in treatment: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

Wolf, D. , Yau, C. , Magbanua, M. , Boudreau, A. , Davis, S. , Haqq, C. ... - SABCS - Cancer Res - 2012

Abstract - Secondary - Primary - Correl Sci NOS - CALGB-150007 , CALGB-150012

Discovery of a new phosphoHER2+/FISH- molecular subtype of human breast cancer by functional pathway mapping

Wulfkuhle, J. , Pierobon, M. , Laird, J. , Espina, V. , Liotta, L. ... - ASCO - J Clin Oncol - 2009

Abstract - Secondary - Primary - Correl Sci NOS - CALGB-150007

Protein pathway activation mapping of I-SPY 1 biopsy specimens identifies new network focused drug targets for patients with HR+/HER2– tumors

Wulfkuhle, J. , Yau, C. , Gallagher, R. , Wolf, D. , Calvert, V. ... - SABCS - Cancer Res - 2012

Abstract - Secondary - Primary - Correl Sci NOS - CALGB-150007 , CALGB-150012

Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping

Wulfkuhle, Julia D. , Berg, Daniela , Wolff, Claudia , Langer, Rupert ... - - Clin Cancer Res - 2012

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150007